Annual CFO
$7.78B$107.74M-1.37%
Summary
- Current Value
- As of today, GSK annual cash from operations is $7.78B, down -1.37% on
- Historical Performance
- GSK annual cash from operations is down -21.43% over the past 3 years, and down -15.43% over the past 5 years
- All-Time High Comparison
- GSK annual cash from operations is currently -37.88% below its historical high of $12.53B set on
- 3-Year Low Comparison
- GSK annual cash from operations is at its 3-year low
- Sector Comparison
- GSK annual cash from operations is higher than 98.47% of companies in Healthcare sector
Cash From Operations Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Operations | $7.78B | -1.4% | -21.4% | -15.4% | -30.8% | |
| Quarterly Cash From Operations | $3.03B | +11.2% | +108.8% | +192.9% | +78.7% | |
| TTM Cash From Operations | $9.75B | +12.8% | -11.8% | +7.8% | -8.8% | |
| Price | $48.22 | +44.2% | +36.3% | +24.4% | +27.6% | |
| Annual Cash From Investing | -$1.77B | +26.2% | +28.0% | +74.5% | +72.5% | |
| Annual Cash From Financing | -$5.24B | +13.6% | +44.1% | -338.1% | -67.5% | |
| Annual Free Cash Flow | $3.97B | -20.2% | -36.5% | -38.4% | -52.2% | |
| Annual CAPEX | $3.81B | +30.8% | +4.4% | +38.1% | +29.6% | |
| Annual Net Income | $3.77B | -42.9% | -22.0% | -43.9% | -57.6% |
Cash From Operations Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $8.16B | N/A | -4.6% |
| 5Y | $9.91B | -21.4% | |
| All | $12.53B | -37.9% |
Cash From Operations Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $7.78B | at low | |
| 5Y | $7.78B | at low | |
| All | $1.75B | +344.2% |
Cash From Operations History
FAQ
What is the current annual cash from operations of GSK?
As of today, GSK annual cash from operations is $7.78B
What is 1-year change in GSK annual cash from operations?
GSK annual cash from operations is down -1.37% year-over-year
What is 3-year change in GSK annual cash from operations?
GSK annual cash from operations is down -21.43% over the past 3 years
How far is GSK annual cash from operations from its all-time high?
GSK annual cash from operations is currently -37.88% below its historical high of $12.53B set on December 31, 2008
How does GSK annual cash from operations rank versus sector peers?
GSK annual cash from operations is higher than 98.47% of companies in Healthcare sector
When is GSK next annual earnings release?
The next annual earnings release for GSK is on
Quarterly CFO
$3.03B$561.38M+22.76%
Summary
- Current Value
- As of today, GSK quarterly cash from operations is $3.03B, up +22.76% on
- Historical Performance
- GSK quarterly cash from operations is up +11.17% year-over-year, and up +108.75% over the past 3 years
- All-Time High Comparison
- GSK quarterly cash from operations is currently -40.84% below its historical high of $5.12B set on
- 3-Year Low Comparison
- GSK quarterly cash from operations is +2522.89% above its 3-year low of $115.43M reached on
- Sector Comparison
- GSK quarterly cash from operations is higher than 98.63% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Operations | $3.03B | +22.8% | +11.2% | +108.8% | +192.9% | |
| Annual Cash From Operations | $7.78B | – | -1.4% | -21.4% | -15.4% | |
| TTM Cash From Operations | $9.75B | +3.2% | +12.8% | -11.8% | +7.8% | |
| Price | $48.22 | +9.3% | +44.2% | +36.3% | +24.4% | |
| Quarterly Cash From Investing | -$2.15B | -160.6% | -125.7% | +57.1% | -199.8% | |
| Quarterly Cash From Financing | -$1.71B | +38.5% | -10.9% | +2.3% | +67.9% | |
| Quarterly Free Cash Flow | $1.82B | +11.7% | +10.5% | +105.2% | +726.9% | |
| Quarterly CAPEX | $1.20B | +44.4% | +12.2% | +114.3% | +47.9% | |
| Quarterly Net Income | $2.89B | +31.5% | +3321.0% | +215.7% | +56.5% |
Quarterly Cash From Operations Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.03B | at high | |
| 3Y | $3.62B | -16.3% | |
| 5Y | $4.70B | -35.6% | |
| All | $5.12B | -40.8% |
Quarterly Cash From Operations Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.42B | +113.0% | |
| 3Y | $115.43M | +2522.9% | |
| 5Y | $115.43M | +2522.9% | |
| All | -$2.73B | +210.9% |
Quarterly Cash From Operations History
FAQ
What is the current quarterly cash from operations of GSK?
As of today, GSK quarterly cash from operations is $3.03B
What is GSK quarterly cash from operations most recent change?
GSK quarterly cash from operations was up +22.76% on September 1, 2025
What is 1-year change in GSK quarterly cash from operations?
GSK quarterly cash from operations is up +11.17% year-over-year
How far is GSK quarterly cash from operations from its all-time high?
GSK quarterly cash from operations is currently -40.84% below its historical high of $5.12B set on December 31, 2018
How does GSK quarterly cash from operations rank versus sector peers?
GSK quarterly cash from operations is higher than 98.63% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
TTM CFO
$9.75B$304.16M+3.22%
Summary
- Current Value
- As of today, GSK TTM cash from operations is $9.75B, up +3.22% on
- Historical Performance
- GSK TTM cash from operations is up +12.81% year-over-year, and down -11.75% over the past 3 years
- All-Time High Comparison
- GSK TTM cash from operations is currently -25.58% below its historical high of $13.10B set on
- 3-Year Low Comparison
- GSK TTM cash from operations is +109.46% above its 3-year low of $4.65B reached on
- Sector Comparison
- GSK TTM cash from operations is higher than 98.91% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Operations | $9.75B | +3.2% | +12.8% | -11.8% | +7.8% | |
| Annual Cash From Operations | $7.78B | – | -1.4% | -21.4% | -15.4% | |
| Quarterly Cash From Operations | $3.03B | +22.8% | +11.2% | +108.8% | +192.9% | |
| Price | $48.22 | +9.3% | +44.2% | +36.3% | +24.4% | |
| TTM Cash From Investing | -$6.06B | -24.6% | -10000.0% | +44.3% | -361.7% | |
| TTM Cash From Financing | -$4.09B | -4.3% | +52.0% | -10000.0% | +67.1% | |
| TTM Free Cash Flow | $5.64B | +3.2% | +5.3% | -33.1% | -11.1% | |
| TTM CAPEX | $4.11B | +3.3% | +25.0% | +57.1% | +52.4% | |
| TTM Net Income | $7.96B | +54.4% | +121.5% | +66.2% | -11.3% |
TTM Cash From Operations Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $9.75B | at high | |
| 3Y | $9.75B | at high | |
| 5Y | $13.10B | -25.6% | |
| All | $13.10B | -25.6% |
TTM Cash From Operations Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $7.86B | N/A | +24.1% |
| 3Y | $4.65B | +109.5% | |
| 5Y | $4.65B | +109.5% | |
| All | $1.75B | +457.4% |
TTM Cash From Operations History
FAQ
What is the current TTM cash from operations of GSK?
As of today, GSK TTM cash from operations is $9.75B
What is GSK TTM cash from operations most recent change?
GSK TTM cash from operations was up +3.22% on September 1, 2025
What is 1-year change in GSK TTM cash from operations?
GSK TTM cash from operations is up +12.81% year-over-year
How far is GSK TTM cash from operations from its all-time high?
GSK TTM cash from operations is currently -25.58% below its historical high of $13.10B set on June 30, 2022
How does GSK TTM cash from operations rank versus sector peers?
GSK TTM cash from operations is higher than 98.91% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
Data Sources & References
- GSK Official Website www.gsk.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1131399/000113139925000007/0001131399-25-000007-index.htm
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk